Modelling and dynamic assessment of integrated health and care pathways enhancing response capacity of health systems
Following a packed and complex Phase I that ended on 30 November 2024, all seven suppliers submitted a tender for the next phase.
While Phase I was mainly characterised by conceptual work, the following Phase II will be dedicated to the development of functional solution prototypes.
We had a kick-off meeting with the three remaining suppliers on 15 January and are now looking forward working with them and are committed to collaborate to ensure continued progress.
Phase II is dedicated to the development of prototypes for functional solutions. The first prototypes will be ready by mid-February, the final ones in late spring.
Phase I of Dynamo began on 1 August 2024 with seven providers. Until the end of Phase I, the suppliers and the buyers group will work together to sharpen the ideas behind the solutions to allow the suppliers to ultimately submit a (hopefully good) offer for Phase II, which will begin in early 2025.
The Dynamo tender contains all the requirements of our procurers, supplemented with the recommendations and advice from the open market consultation.
Each of our procurers had an OMC event in their local language - Treviso (Italy) on 22 June, Athens (Greece) on 13 June, Lisbon (Portugal) on 23 June, Barcelona (Spain) on 15 June, Wales (UK) on 7 June - plus one big online event on 6 July.
What is PCP?
In pre-commercial procurement (PCP), public procures buy Research & Development (R&D) from several competing suppliers in parallel to compare alternative approaches and identify the most cost-effective solutions that the market can deliver for their requirements. R&D is divided into phases (solution design, prototyping, initial development and validation/testing of a limited number of initial products), with the number of competing R&D providers reduced after each R&D phase.